Are you holding Master’s degree and looking for fully funded PhD positions? University of Plymouth, England invites online application for multiple funded PhD Programs / fully funded PhD positions in various research areas.
Candidates interested in fully funded PhD positions can check the details and may apply as soon as possible. Interested and eligible applicants may submit their online application for PhD programs via the University’s Online Application Portal.
1. Fully Funded PhD Position in Understanding the role of the Mas receptor in demyelinating disease and injury
Summary of PhD Program:
Multiple Sclerosis (MS) is a complex neurological disorder with an unknown aetiology and multifaceted pathophysiology. Whilst understanding and therapeutics within this field have been substantial and have improved the lives of many individuals living with MS, there is still an unmet need for interventions that can either protect or repair the nervous system. To develop appropriate therapies that can meet this challenge it is vital that we understand the pathological events following injury and the responses initiated during repair.
Application Deadline: 3 May 2024
2. Fully Funded PhD Position in Identification of lung cancer patients at higher risk for brain metastasis using microfluidics
Summary of PhD Program:
Up to 55% of the patients with advanced non-small cell lung cancer (NSCLC) develop brain metastases with a median survival of 2–3 and 4–6 months in untreated and treated patients, respectively. Due to the location of metastatic lesions, surgical resection is limited, and chemotherapy is quite ineffective due to the blood brain barrier. It is thus crucial to identify patients at higher risk for brain metastasis at an early stage. Brain metastasis has been ascribed to the presence of subsets of circulating tumour cells (CTCs) that transmigrate through the blood brain barrier and thrive in the brain.
Application Deadline: 31 May 2024
Follow FellowshipBard for daily updates!
3. Fully Funded PhD Position in role of SQSTM1/p62 in Drosophila melanogaster models of neurodegeneration
Summary of PhD Program:
Neurodegenerative disorders including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) are a group of conditions characterised by the progressive degeneration of the structure and function of the nervous system, collectively affecting more than 50 million people worldwide. Neuroinflammation, potentially triggered by infection, proteotoxic and/or oxidative stress, is heavily implicated in the pathogenesis and progression of neurodegenerative disorders.
